S&P Futures
3,985.75 +7.75 (+0.19%) Dow Futures
32,378.00 +59.00 (+0.18%) Nasdaq Futures
12,872.25 +18.25 (+0.14%) Russell 2000 Futures
1,741.60 +9.10 (+0.53%) Crude Oil
70.08 +0.12 (+0.17%) Gold
1,988.90 -7.00 (-0.35%)
Biovica International AB (publ) (BIOVIC-B.ST)
Chart Events
Performance Outlook
| Previous Close | 8.38 |
| Open | 8.30 |
| Bid | 8.15 x 0 |
| Ask | 8.20 x 0 |
| Day's Range | 8.13 - 8.37 |
| 52 Week Range | 7.65 - 49.95 |
| Volume | |
| Avg. Volume | 143,130 |
| Market Cap | 380.416M |
| Beta (5Y Monthly) | 1.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.81 |
| Earnings Date | Jun 21, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for BIOVIC-B.ST
Related Research
- ACCESSWIRE
Q3 Interim Report November -January 2022/2023
Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) DiviTum® TKa ready for clinical use in the US
- ACCESSWIRE
Nomination Committee for Biovica for the 2023 Annual General Meeting
Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) The Nomination Committee prior to the 2023 Annual General Meeting will consist of three members, who shall represent the two shareholders with the highest number of shares who accept the assignment to be part of the Nomination Committee as of December 31, 2022, and the Chairman of the Board.
- ACCESSWIRE
Biovica Receives CLIA Certification
Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, today announces that the company's test laboratory in San Diego, California, has received CLIA certification allowing Biovica to begin commercial sales of DiviTum® TKa on the US market.
